A Study of Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)

Clinical trial NCT00882999 · COMPLETED

Trial details

NCT number: NCT00882999
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsing-Remitting Multiple Sclerosis

Start date: 2009-04-01
Primary completion: 2011-02-01
Enrollment: 245

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.